In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

CMC Implementation

Successful implementation of a CMC program depends on selecting the optimum formulation, identifying and managing capable vendors, choosing the optimum dosage formulation, and validating a bioanalytical assay method. PharmaNet Consulting professionals have the expertise and practical understanding to enable you to implement a well designed, highly effective CMC program.

 

PharmaNet professionals available for consultation on this topic include:

 

Andrew Chang, PhD

Executive Director, PharmaNet Consulting

 

Francois Xavier Lacasse, PhD

Director, Drug Development, Scientific and Regulatory Affairs, Anapharm


Stephane Lamouche, MSc, PhD

Project Manager, Drug Development, Scientific and Regulatory Affairs, Anapharm

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390